ArticleFrontiers in cardiovascular medicine2023

The potential of sodium-glucose cotransporter 2 inhibitors for the treatment of systemic right ventricular failure in adults with congenital heart disease.

Ralph M L Neijenhuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.